Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 Mice

Toxicologic Pathology

Volumn 32, Issue 4, 2004, Pages 474-481

  Okamura, Miwa ^a   Moto, Mitsuyoshi ^a   Kashida, Yoko ^a   Machida, Noboru ^a   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

26 Week carcinogenicity study; Multi organ carcinogen; N bis(2 hydroxypropyl)nitrosamine (DHPN); rasH2 mice; Transgene; Transgenic mouse model

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; DRINKING WATER;

ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; LIVER SARCOMA; LONG TERM EXPOSURE; LUNG ADENOMA; LUNG CARCINOMA; MALE; MOUSE; MYOPATHY; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR; SQUAMOUS CELL METAPLASIA; STATISTICAL ANALYSIS; SURVIVAL; URETHRA TUMOR; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, RAS; HEMANGIOSARCOMA; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; NITROSAMINES; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TOXICITY TESTS, CHRONIC; TRANSGENES; URETHRAL NEOPLASMS;

ANIMALIA; MUS MUSCULUS;

EID: 3242885857     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490483315     Document Type: Article

References (34)

1. Bai, F., Nakanishi, Y., Takayama, Y., Pei, X. H., Tokiwa, H., and Hara, N. (1998). Ki-ras mutation and cell proliferation of lung lesions induced by 1-nitropyrene in A/J mice. Mol Carcinog 22, 258-64.
2. Doi, S. T., Kimura, M., and Katsuki, M. (1994). Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice. Jpn J Cancer Res 84, 801-07.
3. Eisenbrand, G., Blankart, M., Sommer, H., and Weber, B. (1991). N-nitrosoalkanolamines in cosmetics IARC Sci Publ 105, 238-14.
4. Hiasa, Y., Kitahori, Y., Kitamura, M., Nishioka, H., Yane, K., Fukumoto, M., Ohshima, M., Nakaoka, S., and Nishii, S. (1991). Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl)nitrosamine. Carcinogenesis 12, 873-7.
5. Hiasa, Y., Ohshima, M., Kitahori, Y., Yuasa, T., Fujita, T., and Iwata, C. (1982). Promoting effects of 3-amino-1.2,4-triazole on the development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. Carcinogenesis 3, 381-4.
6. Issenberg, P., Conrad, E. E., Nielsen. J. W., Klein, D. A., and Miller, S. E. (1984). Determination of N-nitrosobis(2-hydroxypropyl)amine in environmental samples. IARC Sci Publ 57, 43-50.
7. Kawano, R., Nishisaka, T., Takeshima, Y., Yonehara, S., and Inai, K. (1995). Role of point mutation of the K-ras gene in tumorigenesis of B6C3F1 mouse lung lesions induced by urethane. Jpn J Cancer Res 86, 802-10.
8. Kitahori, Y., Hiasa, Y., Konishi, N., Enoki, N., Shimoyama, T., and Miyashiro, A. (1984). Effect of propylthiouracil on the thyroid tumorigenesis induced by N-bis(2-hydroxypropyl) nitrosamine in rats. Carcinogenesis 5, 657-60.
9. Kitada, H., Tsutsumi, M., Tsujiuchi, T., Takahama, M., Fukuda, T., Narita, N., and Konishi, Y. (1996). Frequent mutation of Ki-ras gene but no mutation of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2- hydroxypropyl)amine in rats. Mol Carcinog 15, 276-83.
10. Kokkinakis, D. M. (1992). Alkylation of rodent tissue DNA induced by N-nitrosobis(2-hydroxypropyl)amine. Carcinogenesis 13, 759-65.
11. Kokkinakis, D. M., Scarpelli, D. G., Subbarao, V., and Hollenberg, P. F. (1987). Species differences in the metabolism of N-nitroso(2-hydroxypropyl)(2- oxopropyl)amine. Carcinogenesis 8, 295-303.
12. Konishi, Y., Ikeda, T., Yoshimura, H., Kawabata, A., and Mikami, R. (1979). Carcinogenic effect of N-bis(2-hydroxypropyl)nitrosamine by a single administration in rats. Cancer Lett 6, 115-9.
13. Konishi, Y., Kondo, H., Ikeda, T., Kawabata, A., Shoji, Y., and Denda, A. (1978a). Effect of dose on the carcinogenic activity of orally administered N-bis(2-hydroxypropyl)nitrosamine in rats. Gann 69, 573-7.
14. Konishi, Y., Kondo, H., Inui, S., Denda, A., Ikeda, T., and Kojima, K. (1978b). Organotropic effect of N-bis (2-hydroxypropyl)nitrosamine: production of lung and liver tumors by its oral administration in mice. Gann 69, 77-84.
15. Maruyama, C., Tomisawa, M., Wakana, S., Yamazaki, H., Kijima, H., Suemizu, H., Ohnishi, Y., Urano, K., Hioki, K., Usui, T., Nakayama, M., Tsuchida, T., Mitsumori, K., Nomura, T., Tamaoki, N., and Ueyama, Y. (2001). Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice. Oncol Rep 8, 233-7.
16. Mitsumori, K., Koizumi, H., Nomura, T., and Yamamoto, S. (1998). Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol 26, 520-31.
17. Mitsumori, K., Wakana, S., Yamamoto, S., Kodama, Y., Yasuhara, K., Nomura, T., Hayashi, Y., and Maronpot, R. R. (1997). Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mole Carcinog 20, 298-307.
18. Mori, Y., Takahashi, H., Yamazaki, H., Toyoshi, K., Makino, T., Yokose, Y., and Konishi, Y. (1984). Distribution, metabolism and excretion of N-nitrosobis(2-hydroxypropyl)amine in Wistar rats. Carcinogenesis 5, 1443-7.
19. Mori, I., Yasuhara, K., Hayashi, S., Nonoyama, T., Nomura, T., and Mitsumori, K. (2000). Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototypr c-Ha-ras gene. Cancer Lett 153, 199-209.
20. Morton, D., Alden, C. L., Roth, A. J., and Usui, T. (2002). The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol 30, 139-46.
21. Ogawa, K., Imaida, K., Masui, T., Kawabe, M., Hasegawa, R., Kato, K., Ito, N., and Shirai, T. (1996). Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant form of the human c-Ha-ras transgene. Carcinogenesis 17, 341-5.
22. Pour, P., Mohr, U., Cardesa, A., Althoff, J., and Kruger, F. W. (1975). Pancreatic neoplasms in an animal model: morphological, biological, and comparative studies. Cancer 36, 379-89.
23. Saito, A., Kimura, M., Takahashi, R., Yokoyama, M., Nomura, T., Izawa, M., Sekiya, T., Nishimura, S., and Katsuki, M. (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgene. Oncogene 5, 1195-200.
24. Shirai, T., Kurata, Y., Fukushima, S., and Ito, N. (1984). Dose-related induction of lung, thyroid and kidney tumors by N-bis(2-hydroxypropyl) nitrosamine given orally to F344 rats. Gann 75, 502-7.
25. Suemizu, H., Muguruma, K., Maruyama, C., Tomisama, M., Kimura, M., Hioki, K., Shimozawa, N., Ohnishi, Y., Tamaoki, N., and Nomura, T. (2002). Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Mol Carcinogen 34, 1-9.
26. Takegawa, K., Mitsumori, K., Onodera, H., Shimo, T., Kitaura, K., Yasuhara, K., and Hirose, M. (2000). Studies on the carcinogenicity of potassium iodide in F344 rats. Food Chem Toxicol 38, 773-81.
27. Tamaoki, N. (2001). The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol 29(suppl), 81-9.
28. Tomisawa, M., Suemizu, H., Ohnishi, Y., Maruyama, C., Urano, K., Usui, T., Yasuhara, K., Tamaoki, N., and Mitsumori, K. (2003). Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice. Toxicol Lett 142, 111-7.
29. Torii, M., Itoh, F., Yabuuchi, K., Ohno, K., Kominami, G., Hirano, K., Tasaki, T., and Nara, H. (2001). Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice. J Toxicol Sci 26, 61-73.
30. Tsuchiya, T., Kobayashi, K., Sakairi, T., Goto, K., Okada, M., Sano, F., Sugimoto, J., Morohashi, T., Usui, T., and Mutai, M. (2002). Skeletal myopathy in transgenic mice carrying human prototype c-Ha-ras gene. Toxicol Pathol 30, 501-6.
31. Tsutsumi, M., Masutani, M., Nozaki, T., Kusuoka, O., Tsujiuchi, T., Nakagama, H., Suzuki, H., Konishi, Y., and Sugimura, T. (2001). Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis 22, 1-3.
32. Usui, T., Mutai, M., Hisada, S., Takaoka, M., Soper, K. A., McCullough, B., and Alden, C. (2001). CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol 29 (suppl), 90-108.
33. Yamamoto, S., Hayashi, Y., Mitsumori, K., and Nomura, T. (1997). Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene. Lab Anim Sci 47, 121-6.
34. Yamamoto, S., Mitsumori, K., Kodama, Y., Matsunuma, N., Manabe, S., Okamiya, H., Suzuki, H., Fukuda, T., Sakamaki, Y., Sunaga, M., Nomura, G., Hioki, K., Wakana, S., Nomura, T., and Hayashi, Y. (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis 17, 2455-61.